help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huggenvik, J. I.
Right arrow Articles by Sharma, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggenvik, J. I.
Right arrow Articles by Sharma, R. P.

Molecular Endocrinology, Vol 7, 543-550, Copyright © 1993 by Endocrine Society


ARTICLES

Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-A

JI Huggenvik, MW Collard, YW Kim and RP Sharma
Center for Environmental Toxicology, Utah State University, Logan 84322- 5600.

Retinoic acid receptors (RARs) are ligand-activated nuclear transcription factors that belong to the steroid-thyroid hormone receptor superfamily. We have used the transient transfection of a retinoic acid-responsive reporter plasmid (RARECAT) to investigate the potential interactions between the retinoic acid (RA) and cAMP signaling pathways. Cotransfections of expression plasmids for the catalytic (C) subunits of cAMP-dependent protein kinase with RARECAT showed ligand-independent activation in both CV-1 and HeLa cells and a further 2-fold increase in RARECAT activity in the presence of RA. In CV-1 cells, cotransfections of the expression plasmids for RAR and the C-subunits produced increases in RARECAT activity (12- and 8-fold in the absence of ligand and 21- and 15-fold in the presence of RA for the C alpha- and C beta-isoforms, respectively). Cotransfections of both the C beta-subunit and RAR expression plasmids in HeLa cells produced 22- and 114-fold increases in RARECAT activity in the absence and presence of RA, respectively. These results provide evidence to suggest that the RA and cAMP signaling pathways are coupled, and signaling cross-talk may occur through the direct phosphorylation of RARs by the C-subunit as indicated by in vitro phosphorylation of the receptor.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-H. Cheng, P. Yin, Q. Xue, B. Yilmaz, M. I. Dawson, and S. E. Bulun
Retinoic Acid (RA) Regulates 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometrium: Interaction of RA Receptors with Specificity Protein (SP) 1/SP3 for Estradiol Metabolism
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1915 - 1923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Coleman, M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith
Mechanistic Differences in the Activation of Estrogen Receptor-alpha (ERalpha )- and ERbeta -dependent Gene Expression by cAMP Signaling Pathway(s)
J. Biol. Chem., April 4, 2003; 278(15): 12834 - 12845.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Doucas, Y. Shi, S. Miyamoto, A. West, I. Verma, and R. M. Evans
Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor
PNAS, October 4, 2000; (2000) 220413297.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
J. P. Northrop, D. Nguyen, S. Piplani, S. E. Olivan, S. T-S. Kwan, N. F. Go, C. P. Hart, and P. J. Schatz
Selection of Estrogen Receptor {beta}- and Thyroid Hormone Receptor {beta}-Specific Coactivator-Mimetic Peptides Using Recombinant Peptide Libraries
Mol. Endocrinol., May 1, 2000; 14(5): 605 - 622.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
J. I. Huggenvik, R. J. Michelson, M. W. Collard, A. J. Ziemba, P. Gurley, and K. A. Mowen
Characterization of a Nuclear Deformed Epidermal Autoregulatory Factor-1 (DEAF-1)-Related (NUDR) Transcriptional Regulator Protein
Mol. Endocrinol., October 1, 1998; 12(10): 1619 - 1639.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S.-H. Hong, C.-W. Wong, and M. L. Privalsky
Signaling by Tyrosine Kinases Negatively Regulates the Interaction between Transcription Factors and SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) Corepressor
Mol. Endocrinol., August 1, 1998; 12(8): 1161 - 1171.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
B. L. Wagner, J. D. Norris, T. A. Knotts, N. L. Weigel, and D. P. McDonnell
The Nuclear Corepressors NCoR and SMRT Are Key Regulators of Both Ligand- and 8-Bromo-Cyclic AMP-Dependent Transcriptional Activity of the Human Progesterone Receptor
Mol. Cell. Biol., March 1, 1998; 18(3): 1369 - 1378.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. M. Akmal, J. M. Dufour, M. Vo, S. Higginson, and K. H. Kim
Ligand-Dependent Regulation of Retinoic Acid Receptor {alpha} in Rat Testis: In Vivo Response to Depletion and Repletion of Vitamin A
Endocrinology, March 1, 1998; 139(3): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Bai, B. G. Rowan, V. E. Allgood, B. W. O'Malley, and N. L. Weigel
Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation
J. Biol. Chem., April 18, 1997; 272(16): 10457 - 10463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Leitman, C. H.R.M. Costa, H. Graf, J. D. Baxter, and R. C.J. Ribeiro
Thyroid Hormone Activation of Transcription Is Potentiated by Activators of cAMP-dependent Protein Kinase
J. Biol. Chem., September 6, 1996; 271(36): 21950 - 21955.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Folkers, E. C. van Heerde, and P. T. van der Saag
Activation Function 1 of Retinoic Acid Receptor beta2 Is an Acidic Activator Resembling VP16
J. Biol. Chem., October 6, 1995; 270(40): 23552 - 23559.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lefebvre, M.-P. Gaub, A. Tahayato, Céc. Rochette-Egly, and P. Formstecher
Protein Phosphatases 1 and 2A Regulate the Transcriptional and DNA Binding Activities of Retinoic Acid Receptors
J. Biol. Chem., May 5, 1995; 270(18): 10806 - 10816.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Doucas, Y. Shi, S. Miyamoto, A. West, I. Verma, and R. M. Evans
Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor
PNAS, October 24, 2000; 97(22): 11893 - 11898.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society